CAS: 86483-48-9; 1-Cyclopropyl-6-Fluoro-4-Oxo-7-(Piperazin-1-yl)-1,4-Dihydroquinoline-3-Carboxylic Acid Xhydrochloride

该化合物是一种化学化合物,其特点是quinoline结构,这是一种含有氮原子的双环芳香化合物,该物质具有环丙基化合物和氟芳基原子的特点,有助于其独特的药理特性;存在一种氟丙基氨基苯与生物目标可能发生相互作用,使其对药用化学,特别是药品的开发感兴趣;作为盐盐,它通常在水中更容易溶解,提高其生物利用率;该化合物可能展示各种生物活动,包括抗微生物或抗扰动效应,尽管具体活动将取决于其分子相互作用和使用环境;安全性和处理预防措施与任何化学品一样,由于潜在的毒性或再活性,至关重要;需要进行进一步研究,以充分阐明其在治疗环境中的特性和用途.

结构式图片

上下游产品

piperazine 7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid dimethyl sulfoxide1-cyclopropyl-6-fluoro-7-(4-formylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid enrofloxacin

合成工艺路线路线简述

    环丙沙星置于盐酸体系中,用 1,4-二氧六环,二氯甲烷 作为反应溶剂,化学反应 1.0H,以95%的收率获得产物环丙沙星盐酸盐
    参考文献: Antibiotic Resistance Breakers[fr] Agents De Rupture De Résistance Aux Antibiotiques
    标题: Antibiotic Resistance Breakers[fr] Agents De Rupture De Résistance Aux Antibiotiques
    摘要:该发明涉及公式(a1)的抗生素化合物及其药学上可接受的盐,溶剂化合物,互变异构体和它们的组合,其中x和l是可选的连接物,Ra或r1中的一个包括ar1,其中ar1是一种抗生素耐药性破坏基团,包括可选择取代的c6-10芳基,C7-13芳基烷基,C5-10杂芳基,C6-13杂芳基烷基,C5-10杂环烷基,C6-13杂环烷基,C3-10碳环烷基,C4-13碳环烷基,-C(=nr')-Nr'R''或-ch2-Ch=ch2基团;在将该化合物用于细菌感染后,该基团减少或预防外流.该发明还公开了包括公式(a1)化合物的药物组合物以及将这些化合物用作药物的用途,特别是用于治疗细菌感染,如耐药性细菌感染.

    海关参考信息

    专利信息


    专利号:US-8557979-B2
    优先权日:2004-06-10
    标题 :Carbapenem antibacterials with gram-negative activity and processes for their preparation
    发明人:CHOI WOO-BAEG; KOWALIK EWA
    权利人:CHOI WOO-BAEG; KOWALIK EWA; FOB SYNTHESIS INC
    摘要:The present invention provides β-methyl carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment. The present invention is also in the field of synthetic organic chemistry and is specifically provides an improved method of synthesis of β-methyl carbapenems which are useful as antibacterial agents.

    专利号:US-10933051-B2
    优先权日:2017-06-09
    标 题 :Carbapenem compounds and compositions for the treatment of bacterial infections
    发明人:CHOI WOO-BAEG; TOMIOKA TAKASHI; JOO HYUNG-YEUL; TRUONG PHONG; MIN BRIAN
    权利人:FOB SYNTHESIS INC
    摘要:The present invention provides carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections, including drug resistant or multiple-drug resistant bacterial infections, and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment.

    专利号:WO-2012127505-A3
    优先权日:2011-03-21
    标题 :Improved process for the preparation of ciprofloxacin and its acid addition salts
    发明人:DAVULURI RAMAMOHAN RAO; PONNAIAH RAVI; BAWANE SUNIL; PATHY ASHOK KUMAR; MALI SUNIL
    权利人:DAVULURI RAMAMOHAN RAO
    摘要:An improved process for the synthesis of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid (Ciprofloxacin) or and its acid addition salts preferablyhydrochloride salt with high yield and high purity, the process comprising of reacting 6-fluoro-7-chloro-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid with piperazine in presence of a catalyst in an organic solvent.

    专利号:US-9693999-B2
    优先权日:2011-01-26
    标题:Small molecule RNase inhibitors and methods of use
    发明人:DUNMAN PAUL M; OLSON PATRICK D; CHILDERS WAYNE
    权利人:UNIV ROCHESTER; UNIV NEBRASKA; Temple University—Of the Commonwealth System of Higher Education
    摘要:Small molecule inhibitors of bacterial ribonuclease (e.g., RnpA) and methods for their synthesis and use are described herein. The methods of using the compounds include treating and preventing microbial infections and inhibiting bacterial ribonuclease. Also described herein are methods of identifying compounds for treating or preventing a microbial infection.

    专利号:US-11993606-B2
    优先权日:2015-10-16
    标题:Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
    发明人:MOHAMED MOHAMED-ESLAM F; OTHMAN AHMED A; PANGAN AILEEN L; SONG IN-HO; KLÜNDER BEN; VOSS JEFFREY W; PADLEY ROBERT J; CAMP HEIDI S
    权利人:ABBVIE INC
    摘要:The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide, solid state forms thereof, and corresponding pharmaceutical compositions, methods of treatment (including treatment of rheumatoid arthritis and various spondyloarthritic conditions, including types of axial spondyloarthritis (axSpA)), kits, methods of synthesis, and products-by-process. In various aspects, provided are methods for treating active non-radiographic axSpA (nr-axSpA) and methods for treating active ankylosing spondylitis (AS).

    专利号:US-11976077-B2
    优先权日:2015-10-16
    标 题 :Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms therof
    发明人:PANGAN AILEEN L; TEIXEIRA HENRIQUE D; MOHAMED MOHAMED-ESLAM F; OTHMAN AHMED A; KLÜNDER BEN; VOSS JEFFREY W; PADLEY ROBERT J; CAMP HEIDI S
    权利人:ABBVIE INC
    摘要:The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide, solid state forms thereof, and corresponding pharmaceutical compositions, methods of treatment (including treatment of rheumatoid arthritis and atopic dermatitis), kits, methods of synthesis, and products-by-process.
    珠海蔚蓝医药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.vitalpharms.com
    电话: 0756-3326819👤
    📞珠海蔚蓝医药有限公司 ⚠️参考联系方式

    销售电话:0756-3326819
    邮箱:sales@vitalpharms.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    新昌国邦进出口有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.xcgbie.com
    电话: 0575-86124382👤
    📞新昌国邦进出口有限公司 ⚠️参考联系方式

    销售电话:0575-86124382
    邮箱:exports@xcgbie.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    浙江京新药业股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jingxinpharm.com
    电话: 0575-86298608👤
    📞浙江京新药业股份有限公司 ⚠️参考联系方式

    销售电话:0575-86298608
    邮箱:hyjmails85@tom.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports., 11(411), 1985
    摘要:Iyakuhin Kenkyu. Study of Medical Supplies., 19(735), 1988
    参考文献:10.1007/s00423-008-0345-z
    摘要:Banasiewicz T, Meissner W, Pyda P, Wierzbicki T, Głyda M, Musiał M, Smoliński S, Iwanik K, Drews M. Partial thyroidectomy under local anaesthesia-the analysis of 49 subsequent cases. Langenbecks Arch Surg. 2008 Sep;393(5):715–9. doi: 10.1007/s00423-008-0345-z.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知